Chimæra analysis suggested that the RB1 locus deletion predates the PTEN mutation and that the BRCA2 and EP300 mutations were acquired in tumor subclones that following RB1 loss, lacked the PTEN mutation (Fig. 7d). The gene discussed is PTEN; the disease is neoplasm.